Nephron Research Adjusts Price Target on DexCom to $125 From $145

MT Newswires00:28 · Ratings

DexCom Is Maintained at Buy by Citigroup

Dow JonesDec 12 03:16 · Ratings

10 BofA U.S. Options Overwriting Ideas

Seeking AlphaDec 12 01:31

Unusual Options Activity: ACI, FTI and Others Attract Market Bets, ACI V/OI Ratio Reaches 75.0

EST Dec 11th Morning Delivery - In the last two hours of trading, 9 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.

Futu NewsDec 12 00:30

DexCom Is Maintained at Overweight by Wells Fargo

Dow JonesDec 11 23:18 · Ratings

Wells Fargo Maintains DexCom(DXCM.US) With Buy Rating, Raises Target Price to $94

Futu NewsDec 11 22:31 · Ratings